Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy…
Roche announced today that it has entered into a definitive merger agreement to acquire Poseida Therapeutics, Inc., a public clinical-stage biopharmaceutical company pioneering…
Read More...
Read More...